Vieito Villar, M., Sepúlveda, J. M., Galvao De Aquiar, V., Hernández-Guerrero, T., Doger, B., Saavedra Gadea, O., . . . Moreno, V. (2023). BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas.
Citación estilo ChicagoVieito Villar, Maria, Juan Manuel Sepúlveda, Vladimir Galvao De Aquiar, T. Hernández-Guerrero, B. Doger, Omar Saavedra Gadea, Cecilia Carmen Carpio Segura, Irene Braña Garcia, y Victor Moreno. BET Inhibitor Trotabresib in Heavily Pretreated Patients With Solid Tumors and Diffuse Large B-cell Lymphomas. 2023.
Cita MLAVieito Villar, Maria, et al. BET Inhibitor Trotabresib in Heavily Pretreated Patients With Solid Tumors and Diffuse Large B-cell Lymphomas. 2023.
Precaución: Estas citas no son 100% exactas.